Gait impairment is more than a motor symptom in Parkinson’s disease
Objective: To examine the relationship of gait impairment of Parkinson's disease (PD) patients with different clinical factors including motor function, non-motor function and cognitive function.…Verbatim patient-reported outcomes and trails making test B (TMT-B) performance in the REACH2HD trial
Objective: Examine the relationship between Trails Making Test B (TMT-B) performance and bothersome cognitive complaints among Huntington Disease (HD) research participants in the REACH2HD randomized-controlled…Metabolic brain changes related to specific cognitive impairment in non-demented Parkinson’s disease patients
Objective: To measure the expression of the Parkinson's disease related cognitive pattern (PDCP) in 18F-FDG-PET brain images of Parkinson's disease (PD) patients and healthy controls…Social cognition assessment in progressive supranuclear palsy: The cognitive interface with frontotemporal dementia
Objective: To explore the cognitive profile of PSP patients in tests of social cognition and to compare their performance to patients with behavioural variant frontotemporal…Defective visual perception in patients with Parkinson’s disease: The impairment of preattentive visual processing in the normal intellectual patients
Objective: In the previous conference, we reported that the impairment of preattentive visual processing could be detected even among subjects considered to have normal cognitive…Occurrence and pattern of cognitive deficits in prodromal Parkinson’s disease
Objective: To assess a possible cognitive impairment and its specific profile in the prodromal phase of Parkinson's disease (PD). Background: Cognitive impairment is common in…Plasma ceramides and glucosylceramides predict cognitive decline among cognitively normal Parkinson’s disease patients
Objective: To determine whether plasma ceramides, glucosylceramides, and their ratios predict cognitive decline among cognitively normal Parkinson's disease (PD) patients. Background: There are no biomarkers…Attention and dopamine: Increased distractibility in Parkinson’s disease
Objective: To determine the interactions between dopamine, Working Memory(WM) and Attentional Control(AC) in Parkinson's disease(PD) patients. Background: WM impairment is common in PD. Studies have…Psychiatric manifestations in the initial motor stage of Parkinson’s disease
Objective: To estimate the prevalence and correlates of neuropsychiatric symptoms (NPS) in a cohort of consecutive patients with Parkinson's disease (PD) recruited in the initial…Vitamin D in early Parkinson’s disease
Objective: To determine serum 25-hydroxy vitamin D (25OHD) concentration at diagnosis and 18 months in incident Parkinson's disease (PD) compared to controls and to investigate…
- « Previous Page
- 1
- …
- 135
- 136
- 137
- 138
- 139
- …
- 141
- Next Page »